Press Release Biocartis NV: Biocartis appoints Randy Polonsky as Chief Financial Officer [Yahoo! Finance]
TALIS BIOMEDICAL CORP (TLIS)
Company Research
Source: Yahoo! Finance
Mechelen, Belgium, 05 November 2024 – Biocartis NV (“Biocartis”), an innovative molecular diagnostics company, announces the appointment of Randy Polonsky as Chief Financial Officer, effective 31 October 2024. This key hire comes at a pivotal time as Biocartis continues to innovate and expand its footprint in the oncology diagnostics sector. Randy brings a wealth of experience in financial planning and analysis, corporate development, operational excellence, and leadership across both public and private equity global companies. Most recently, Randy was VP of FP&A and Corporate Development at Talis Biomedical, where he established a strategy to enhance financial performance while preparing to commercialize a new Point-of-Care diagnostic system. Prior to Talis, Randy worked at Vyaire Medical and CDW, where he held progressively senior roles in finance. “Randy's expertise will be instrumental as we accelerate growth and become profitable,” said Roger Moody, Chief Executive Officer o
Show less
Read more
Impact Snapshot
Event Time:
TLIS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TLIS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TLIS alerts
High impacting TALIS BIOMEDICAL CORP news events
Weekly update
A roundup of the hottest topics
TLIS
Sec Filings
- 10/10/24 - Form SC
- 9/30/24 - Form 15-12G
- 9/20/24 - Form 25-NSE
- TLIS's page on the SEC website